Unichem Laboratories Q4 net profit up 13% at Rs 31.46 cr
New Delhi: Drug firm Unichem Laboratories reported a 13.61 per cent increase in standalone net profit at Rs 31.46 crore for the fourth quarter ended March 31, 2017.
The company had posted a net profit of Rs 27.69 crore in the corresponding quarter of previous fiscal, Unichem Laboratories said in a BSE filing.
Total income from operations during the quarter under review stood at Rs 343.99 crore as against Rs 310.63 crore in the year-ago period.
For the fiscal ended March 31, 2017, the company reported a net profit of Rs 103.86 crore as compared to Rs 100.48 crore in the 2015-16 fiscal.
The companys board has recommended a final dividend of Rs 3 per equity share for FY17.
Shares of the company closed 4.67 per cent up at Rs 253.20 on BSE.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd